$1.22
-0.02-1.21%
At close: -
$1.20
-0.02-1.64%
After Hours: Nov 22, 7:39 PM EDT
Comments
Loading...
bioAffinity Technologies (NASDAQ:BIAF) Stock, Earnings Estimates, EPS, And Revenue
bioAffinity Technologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.160
Quarterly Revenue
$2.4M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$9.4M
Analyze the earnings history of bioAffinity Technologies using advanced sorting and filters.
Data brought to you by Benzinga APIs
bioAffinity Technologies (BIAF) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-0.16 | $-0.15 | -6.67 % |
bioAffinity Technologies (BIAF) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $2.35M | $2.54M | -7.48 % |
FAQ
When is bioAffinity Technologies (NASDAQ:BIAF) reporting earnings?
bioAffinity Technologies ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for bioAffinity Technologies (NASDAQ:BIAF)?
bioAffinity Technologies ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.16, which missed the estimate of $-0.15.
What were bioAffinity Technologies’s (NASDAQ:BIAF) revenues?
bioAffinity Technologies ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.